Süssmuth S[au] - Search Results

Year	Number of Results
2000	1
2001	1
2003	1
2004	1
2005	2
2006	2
2007	3
2008	4
2009	4
2010	4
2011	3
2012	1
2013	4
2014	6
2015	5
2016	2
2017	2
2020	1
2021	1
2022	0

1

[Current cerebrospinal fluid diagnostics for pathogen-related diseases].

Süssmuth SD, Brettschneider J, Spreer A, Wick M, Jesse S, Lewerenz J, Otto M, Tumani H. Süssmuth SD, et al. Nervenarzt. 2013 Feb;84(2):229-44. doi: 10.1007/s00115-012-3701-8. Nervenarzt. 2013. PMID: 23371378 Free PMC article. Review. German.

2

The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation.

Milaneschi Y, Allers KA, Beekman ATF, Giltay EJ, Keller S, Schoevers RA, Süssmuth SD, Niessen HG, Penninx BWJH. Milaneschi Y, et al. Among authors: sussmuth sd. Brain Behav Immun. 2021 Oct;97:167-175. doi: 10.1016/j.bbi.2021.07.007. Epub 2021 Jul 9. Brain Behav Immun. 2021. PMID: 34252568 Free article.

3

Biochemical markers in CSF of ALS patients.

Süssmuth SD, Brettschneider J, Ludolph AC, Tumani H. Süssmuth SD, et al. Curr Med Chem. 2008;15(18):1788-801. doi: 10.2174/092986708785133031. Curr Med Chem. 2008. PMID: 18691039 Review.

4

Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.

Otto M, Bowser R, Turner M, Berry J, Brettschneider J, Connor J, Costa J, Cudkowicz M, Glass J, Jahn O, Lehnert S, Malaspina A, Parnetti L, Petzold A, Shaw P, Sherman A, Steinacker P, Süssmuth S, Teunissen C, Tumani H, Wuolikainen A, Ludolph A; Volcano Group. Otto M, et al. Among authors: sussmuth s. Amyotroph Lateral Scler. 2012 Jan;13(1):1-10. doi: 10.3109/17482968.2011.627589. Amyotroph Lateral Scler. 2012. PMID: 22214350 Free article. Review.

5

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.

Tumani H, Teunissen C, Süssmuth S, Otto M, Ludolph AC, Brettschneider J. Tumani H, et al. Among authors: sussmuth s. Expert Rev Mol Diagn. 2008 Jul;8(4):479-94. doi: 10.1586/14737159.8.4.479. Expert Rev Mol Diagn. 2008. PMID: 18598229 Review.

6

CIS case studies.

Tumani H, Sapunova-Mayer I, Süssmuth SD, Hirt V, Brettschneider J. Tumani H, et al. Among authors: sussmuth sd. J Neurol Sci. 2009 Dec;287 Suppl 1:S7-10. doi: 10.1016/S0022-510X(09)71294-8. J Neurol Sci. 2009. PMID: 20106350

7

Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?

Brettschneider J, Petzold A, Süssmuth S, Tumani H. Brettschneider J, et al. Among authors: sussmuth s. J Neurol. 2009 Jan;256(1):3-12. doi: 10.1007/s00415-009-0097-x. Epub 2009 Feb 16. J Neurol. 2009. PMID: 19267167 Review.

8

The neuropsychology of first impressions: Evidence from Huntington's disease.

Sprengelmeyer R, Young AW, Baldas EM, Ratheiser I, Sutherland CAM, Müller HP, Grön G, Süssmuth SD, Landwehrmeyer GB, Orth M. Sprengelmeyer R, et al. Among authors: sussmuth sd. Cortex. 2016 Dec;85:100-115. doi: 10.1016/j.cortex.2016.10.006. Epub 2016 Oct 21. Cortex. 2016. PMID: 27852003 Free article.

9

Fat-free mass and its predictors in Huntington's disease.

Süssmuth SD, Müller VM, Geitner C, Landwehrmeyer GB, Iff S, Gemperli A, Orth M. Süssmuth SD, et al. J Neurol. 2015 Jun;262(6):1533-40. doi: 10.1007/s00415-015-7753-0. Epub 2015 Apr 23. J Neurol. 2015. PMID: 25904208

10

A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease.

Reilmann R, Rouzade-Dominguez ML, Saft C, Süssmuth SD, Priller J, Rosser A, Rickards H, Schöls L, Pezous N, Gasparini F, Johns D, Landwehrmeyer GB, Gomez-Mancilla B. Reilmann R, et al. Among authors: sussmuth sd. Mov Disord. 2015 Mar;30(3):427-31. doi: 10.1002/mds.26174. Epub 2015 Feb 17. Mov Disord. 2015. PMID: 25689146 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results